NeuBase Therapeutics, Inc. carries a market capitalization of 1.42M, placing it among publicly traded companies globally.
| Market Cap | 1.42M |
| Enterprise Value | N/A |
NeuBase Therapeutics, Inc.'s stock has declined approximately -89.83871% over the past 52 weeks. The 50-day moving average sits at 0.47, while the 200-day moving average is 0.72.
| Beta (5Y) | N/A |
| 52-Week Price Change | -89.83871% |
| 50-Day Moving Average | 0.47 |
| 200-Day Moving Average | 0.72 |
| Average Volume (20 Days) | N/A |
NeuBase Therapeutics, Inc.'s most recent stock split took place on June 15, 2023 with a 20:1 split ratio.
| Last Split Date | 6/15/2023 |
| Split Ratio | 20:1 |